# Safety and Efficacy of CollaRx® Bupivacaine Implant in Men After Open Laparotomy Herniorrhaphy

> **NCT01220024** · PHASE2 · COMPLETED · sponsor: **Innocoll** · enrollment: 50 (actual)

## Conditions studied

- Herniorrhaphy
- Postoperative Pain
- Inguinal Hernia

## Interventions

- **DRUG:** Bupivacaine Collagen Sponge
- **DRUG:** Placebo collagen Sponge

## Key facts

- **NCT ID:** NCT01220024
- **Lead sponsor:** Innocoll
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12-02
- **Primary completion:** 2011-05-18
- **Final completion:** 2011-05-18
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2021-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01220024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01220024, "Safety and Efficacy of CollaRx® Bupivacaine Implant in Men After Open Laparotomy Herniorrhaphy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01220024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*